semaglutide and als GLP-1-related antihyperglycemic medication use is associated with shorter survival in patients with amyotrophic lateral sclerosis diabetes mellitus Semaglutide Shows Secondary Cardiovascular Prevention

Combination therapy: Patients with type 2 diabetes mellitus to improve glycemic control in combination with sulfonylurea derivatives (triple combination: metformin + sitagliptin + sulfonylurea derivative) when diet and exercise regimen in combination with two of these three drugs (metformin, sitagliptin or sulfonylurea derivatives) are not lead to adequate glycemic control

We wanted to make sure people had a sense of how we are perceiving this. In November, the Endocrine Society hosted a virtual science writers conference to discuss differences between FDA-approved medications for obesity and non-approved forms of these drugs

And, critically for this discussion, it slows gastric emptying, the rate at which food moves from your stomach into your small intestine

DIETILFITATO, etc